Temple University Hospital

Futó vizsgálatok

• Még nem toboroz

  An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

  NCT07923526· 2/3. fázis· United Therapeutics· Forrás

• Még nem toboroz

  Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

  NCT07923591· 2. fázis· United Therapeutics· Forrás

• Még nem toboroz

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· 3. fázis· Stanford University· Forrás

• Toboroz

  WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

  NCT07558265· Ohio State University· Forrás

• Toboroz

  Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

  NCT07441681· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

  NCT07455032· 1. fázis· Fox Chase Cancer Center· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT07363694· 2/3. fázis· Pfizer· Forrás

• Toboroz

  Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

  NCT07222410· Fisher and Paykel Healthcare· Forrás

• Toboroz

  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

  NCT07061977· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  NCT07190209· 3. fázis· Sanofi· Forrás

• Toboroz

  Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

  NCT07151768· Temple University· Forrás

• Fut, nem toboroz

  A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06736990· 2. fázis· Calluna Pharma AS· Forrás

• Toboroz

  Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  NCT06616584· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Toboroz

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  NCT07227246· 3. fázis· Joseph Broderick, MD· Forrás

• Toboroz

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· 2. fázis· Avalyn Pharma Inc.· Forrás

• Toboroz

  A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  NCT06890884· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· United Therapeutics· Forrás

• Fut, nem toboroz

  A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

  NCT06588686· 2. fázis· Vicore Pharma AB· Forrás

• Toboroz

  Gastroparesis Registry 4

  NCT05846802· Johns Hopkins Bloomberg School of Public Health· Forrás

• Toboroz

  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

  NCT06559150· 2. fázis· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Forrás

• Toboroz

  Strategy for Improving Stroke Treatment Response

  NCT05948566· 2. fázis· Translational Sciences, Inc.· Forrás

• Toboroz

  Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05571059· 2. fázis· Cumberland Pharmaceuticals· Forrás

• Toboroz

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· 3. fázis· United Therapeutics· Forrás

• Toboroz

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· 3. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás

• Toboroz

  Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  NCT05624996· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

  NCT05851443· 2. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

  NCT05408546· 2. fázis· Translational Sciences, Inc.· Forrás

• Fut, nem toboroz

  Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

  NCT05612035· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

  NCT05633602· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

  NCT04665739· 2. fázis· National Cancer Institute (NCI)· Forrás

• Meghívásos bevonás

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· 3. fázis· United Therapeutics· Forrás

• Fut, nem toboroz

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  NCT05047172· 3. fázis· University of Florida· Forrás

• Fut, nem toboroz

  Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

  NCT05119556· University of Alabama at Birmingham· Forrás

• Fut, nem toboroz

  Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT05096663· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Toboroz

  Assessment of CCM in HF With Higher Ejection Fraction

  NCT05064709· Impulse Dynamics· Forrás

• Fut, nem toboroz

  Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

  NCT05050162· 2/3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

  NCT05097287· 4. fázis· Sanofi· Forrás

• Fut, nem toboroz

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

  NCT03496883· 3. fázis· Joseph Broderick, MD· Forrás

• Meghívásos bevonás

  Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

  NCT04930289· Paragonix Technologies· Forrás

• Toboroz

  Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

  NCT04798261· Penumbra Inc.· Forrás

• Toboroz

  Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  NCT04671667· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT04625647· 2. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

  NCT04760717· 2. fázis· Yale University· Forrás

• Fut, nem toboroz

  Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

  NCT04513717· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Post-Approval Study of the TREO Abdominal Stent-Graft System

  NCT04697784· Bolton Medical· Forrás

• Toboroz

  Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  NCT04423211· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

  NCT04233866· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás

Showing 50 of 87.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Krónikus obstruktív tüdőbetegség (COPD)7 toboroz
• Magas vérnyomás5 toboroz
• Pulmonális artériás hipertónia5 toboroz
• Tüdőrák5 toboroz
• Idiopátiás tüdőfibrózis4 toboroz
• Stroke (szélütés)4 toboroz
• Fej-nyaki daganatok3 toboroz
• Cisztás fibrózis2 toboroz
• Szívelégtelenség2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Bronchiectasis1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Gastroparesis1 toboroz
• Koszorúér-betegség1 toboroz
• Méhnyakrák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

  NCT06899217· 2. fázis· CinDome Pharma, Inc.· Forrás

• Toboroz

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· 2. fázis· Scleroderma Research Foundation, Inc.· Forrás

• Lezárult

  Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

  NCT05671835· 2. fázis· Tvardi Therapeutics, Incorporated· Forrás

• Toboroz

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Lezárult

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  The PEERLESS Study

  NCT05111613· Inari Medical· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· 2. fázis· Genentech, Inc.· Forrás

• Lezárult

  A Study of Surgical Interventions in Fistulizing Conditions

  NCT04940611· Takeda· Forrás

• Lezárult

  Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

  NCT04751487· 3. fázis· Sanofi· Forrás

• Lezárult

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Emergency Department-Initiated Buprenorphine Validation Network Trial

  NCT04225598· 2. fázis· Yale University· Forrás

• Lezárult

  Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

  NCT04173507· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

  NCT04069312· 3. fázis· Johns Hopkins University· Forrás

• Leállították

  Vector Efficacy Cross-Over Pilot Study

  NCT04263532· Philips Clinical & Medical Affairs Global· Forrás

• Lezárult

  Multi-arm Optimization of Stroke Thrombolysis

  NCT03735979· 3. fázis· Washington University School of Medicine· Forrás

• Lezárult

  Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

  NCT03971474· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Sleep for Stroke Management and Recovery Trial

  NCT03812653· University of Michigan· Forrás

• Lezárult

  Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT03845296· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

  NCT03657342· 3. fázis· Zambon SpA· Forrás

• Lezárult

  Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

  NCT03656926· 3. fázis· Zambon SpA· Forrás

• Lezárult

  Gastroparesis Registry 3

  NCT03680859· Johns Hopkins Bloomberg School of Public Health· Forrás

• Toboroz

  Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  NCT03678025· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  NCT03286556· 2. fázis· University of Alabama at Birmingham· Forrás

• Lezárult

  Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  NCT03258554· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

  NCT03365882· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

  NCT03221426· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

  NCT02635009· 2/3. fázis· NRG Oncology· Forrás

• Leállították

  Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

  NCT02408861· 1. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

  NCT02438722· 2/3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· AbbVie· Forrás

• Lezárult

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

  NCT01546987· 3. fázis· Radiation Therapy Oncology Group· Forrás

• Lezárult

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

  NCT01167712· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

  NCT01101451· 3. fázis· GOG Foundation· Forrás

• Lezárult

  Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

  NCT00936390· 3. fázis· Radiation Therapy Oncology Group· Forrás

• Lezárult

  Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

  NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Idiopátiás tüdőfibrózis11 munka · 9 vizsgálat
• Sarcoidosis9 munka · 0 vizsgálat